Trillium Asset Management LLC Has $11 Million Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Trillium Asset Management LLC decreased its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 113,747 shares of the medical instruments supplier’s stock after selling 4,853 shares during the quarter. Trillium Asset Management LLC owned 0.20% of Merit Medical Systems worth $11,001,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the stock. NewSquare Capital LLC acquired a new stake in shares of Merit Medical Systems during the fourth quarter worth about $32,000. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Merit Medical Systems during the fourth quarter worth about $52,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Merit Medical Systems during the third quarter worth about $120,000. Smartleaf Asset Management LLC raised its position in shares of Merit Medical Systems by 237.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,388 shares of the medical instruments supplier’s stock worth $134,000 after purchasing an additional 977 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Merit Medical Systems by 14.7% during the fourth quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock worth $144,000 after purchasing an additional 191 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on MMSI shares. Wells Fargo & Company dropped their price target on Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 26th. Needham & Company LLC dropped their price target on Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a research report on Wednesday, February 26th. Barrington Research dropped their target price on Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 26th. Piper Sandler reissued an “overweight” rating and issued a $116.00 target price (up previously from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Finally, Raymond James lifted their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Tuesday, December 31st. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.78.

Insider Buying and Selling at Merit Medical Systems

In related news, insider Brian G. Lloyd sold 25,000 shares of the business’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $99.50, for a total value of $2,487,500.00. Following the completion of the sale, the insider now directly owns 38,993 shares in the company, valued at $3,879,803.50. The trade was a 39.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Fred P. Lampropoulos sold 31,320 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $103.86, for a total value of $3,252,895.20. Following the completion of the sale, the chief executive officer now owns 1,086,028 shares of the company’s stock, valued at $112,794,868.08. This trade represents a 2.80 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 109,132 shares of company stock worth $11,139,521 over the last ninety days. 3.70% of the stock is currently owned by corporate insiders.

Merit Medical Systems Stock Down 0.7 %

MMSI stock opened at $99.95 on Wednesday. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The business has a 50 day moving average price of $103.69 and a two-hundred day moving average price of $100.70. The company has a market cap of $5.88 billion, a price-to-earnings ratio of 49.00, a P/E/G ratio of 2.34 and a beta of 0.91. Merit Medical Systems, Inc. has a twelve month low of $70.70 and a twelve month high of $111.45.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.